Sullivan, Richard

Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development

Meara, J. G., Leather, A. J. M., Hagander, L., Alkire, B. C., Alonso, N., Ameh, E. A., Bickler, S. W., Conteh, L., Dare, A. J., Davies, J., et al. (2015) · The Lancet

Global Health and SurgeryHealthcare Systems and Reforms

Cited by 3,851

Mortality due to cancer treatment delay: systematic review and meta-analysis

Hanna, T. P., King, W. D., Thibodeau, S., Jalink, M., Paulin, G. A., Harvey-Jones, E., O’Sullivan, D. E., Booth, C. M., Sullivan, R., & Aggarwal, A. (2020) · BMJ

COVID-19 and healthcare impactsGlobal Cancer Incidence and Screening

Cited by 1,742

The global burden of women's cancers: a grand challenge in global health

Ginsburg, O., Bray, F., Coleman, M. P., Vanderpuye, V., Eniu, A., Kotha, S. R., Sarker, M., Huong, T. T., Allemani, C., Dvaladze, A., et al. (2017) · The Lancet

Global Cancer Incidence and ScreeningWomen's cancer prevention and management

Cited by 1,127

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Cherny, N. I., Sullivan, R., Dafni, U., Kerst, J. M., Sobrero, A., Zielinski, C., de Vries, E. G. E., & Piccart, M. J. (2015) · Annals of Oncology

Health Systems, Economic Evaluations, Quality of LifeStatistical Methods in Clinical Trials

Cited by 818

Delivering affordable cancer care in high-income countries

Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., Khayat, D., Boyle, P., Autier, P., Tannock, I. F., et al. (2011) · The Lancet Oncology

Economic and Financial Impacts of CancerHealth Systems, Economic Evaluations, Quality of Life

Cited by 718

Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study

Lai, A. G., Pasea, L., Banerjee, A., Hall, G., Denaxas, S., Chang, W. H., Katsoulis, M., Williams, B., Pillay, D., Noursadeghi, M., et al. (2020) · BMJ Open

COVID-19 and healthcare impactsGlobal Cancer Incidence and Screening

Cited by 447

New policies to address the global burden of childhood cancers

Sullivan, R., Kowalczyk, J. R., Agarwal, B., Ladenstein, R., Fitzgerald, E., Barr, R., Steliarova-Foucher, E., Magrath, I., Howard, S. C., Kruger, M., et al. (2013) · The Lancet Oncology

Advances in Oncology and RadiotherapyGlobal Cancer Incidence and Screening

Cited by 121

Changing global policy to deliver safe, equitable and affordable care for women's cancers

Ginsburg, O., Badwe, R., Boyle, P., Derricks, G., Dare, A., Evans, T., Eniu, A., Jimenez, J., Kutluk, T., Lopes, G., et al. (2017) · The Lancet

Global Cancer Incidence and ScreeningWomen's cancer prevention and management

Cited by 102

Prospective evaluation of artificial intelligence (AI) applications for use in cancer pathways following diagnosis: a systematic review

Macheka, S., Ng, P. Y., Ginsburg, O., Hope, A., Sullivan, R., & Aggarwal, A. (2024) · BMJ Oncology

Artificial Intelligence in Healthcare and EducationAI in cancer detection

Cited by 45

Health service planning to assess the expected impact of centralising specialist cancer services on travel times, equity, and outcomes: a national population-based modelling study

Aggarwal, A., Han, L., van der Geest, S., Lewis, D., Lievens, Y., Borras, J., Jayne, D., Sullivan, R., Varkevisser, M., & van der Meulen, J. (2022) · The Lancet Oncology

Health Services Management and PolicyHealthcare Quality and Management

Cited by 42

Screening for Cancer: Considerations for Low- and Middle-Income Countries

Sullivan, T., Sullivan, R., & Ginsburg, O. M. (2015) · Disease Control Priorities, Third Edition (Volume 3): Cancer

Global Cancer Incidence and ScreeningWomen's cancer prevention and management

Cited by 38